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Abstract
Atypical scrapie or Nor98 has been identified as a transmissible spongiform encephalopathy (TSE) that is clearly
distinguishable from classical scrapie and BSE, notably regarding the biochemical features of the protease-resistant prion
protein PrP
res and the genetic factors involved in susceptibility to the disease. In this study we transmitted the disease from
a series of 12 French atypical scrapie isolates in a transgenic mouse model (TgOvPrP4) overexpressing in the brain ,0.25, 1.5
or 66the levels of the PrP
ARQ ovine prion protein under the control of the neuron-specific enolase promoter. We used an
approach based on serum PrP
c measurements that appeared to reflect the different PrP
c expression levels in the central
nervous system. We found that transmission of atypical scrapie, much more than in classical scrapie or BSE, was strongly
influenced by the PrP
c expression levels of TgOvPrP4 inoculated mice. Whereas TgOvPrP4 mice overexpressing ,66the
normal PrP
c level died after a survival periods of 400 days, those with ,1.56the normal PrP
c level died at around 700 days.
The transmission of atypical scrapie in TgOvPrP4 mouse line was also strongly influenced by the prnp genotypes of the
animal source of atypical scrapie. Isolates carrying the AF141RQ or AHQ alleles, associated with increased disease
susceptibility in the natural host, showed a higher transmissibility in TgOvPrP4 mice. The biochemical analysis of PrP
res in
TgOvPrP4 mouse brains showed a fully conserved pattern, compared to that in the natural host, with three distinct PrP
res
products. Our results throw light on the transmission features of atypical scrapie and suggest that the risk of transmission is
intrinsically lower than that of classical scrapie or BSE, especially in relation to the expression level of the prion protein.
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Introduction
Transmissible Spongiform Encephalopathies (TSEs) are fatal
neuro-degenerative diseases that affect humans and animals, and
include bovine spongiform encephalopathy (BSE) in cattle, scrapie
in small ruminants, chronic wasting disease (CWD) in cervids, and
Creutzfeldt-Jakob disease (CJD) in humans. The precise nature of
the TSE agents is unknown, but a disease-associated (PrP
Sc),
relatively proteinase-K resistant (PrP
res) isoform of the host cellular
prion protein (PrP
c), that co-purifies with infectivity, is supposed to
be the major, if not sole, component of the infectious agent
according to the ‘‘prion hypothesis’’ [1–3].
TSEs are transmissible in their species of origin, but can also
cross species barriers and induce infection and/or disease after
long incubation periods in other mammalian species, notably mice
[4]. In this context transgenic mice expressing the prion protein of
the natural host of the disease are very useful in TSEs transmission
studies, as has been shown for scrapie using ovine transgenic mice
[5,6]. However, more efficient and rapid transmission was
generally obtained with transgenic mice that over-expressed the
physiological concentration of the prion gene whereas transgenic
mice expressing physiological concentrations of PrP
c were less
susceptible to TSE transmission and had longer incubation
periods.
Scrapie transmission is highly dependent on genetic variations
of the host, i.e. polymorphisms of the prnp ovine prion gene at
codons 136 (V: valine or A: alanine), 154 (H: histidine or R:
arginine) and 171 (Q: glutamine, R: arginine or H: histidine) [7,8].
Nevertheless, the scrapie strain and, at least in in vitro experiments,
the prion protein genotype of the animal that is the source of the
infectious agent, are also important in determining scrapie
transmissibility [9–11]. However, since 1998, a novel form of
scrapie has been diagnosed [12,13]. This disease, designated
Nor98 or atypical scrapie clearly differs from classical scrapie,
notably with regard to the molecular and biochemical character-
istics of the corresponding PrP
res and to the genetic factors
involved in susceptibility [14–16].
Transmission studies in a transgenic mouse model over-
expressing high levels of the ovine PrP
VRQ protein had previously
demonstrated transmissibility of the disease from such isolates
[17], but also revealed the uniform features and similarities
between cases previously described in Norway [12], then in France
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the natural host of the disease, successful experimental transmis-
sion has been reported in a single intra-cerebrally infected sheep
[18] whereas no evidence of factors related to an infectious origin
of the disease has been observed in the field [19].
To characterise the transmission features of the TSE agents
involved in scrapie more precisely, factors determining their
transmission in ovine transgenic mice (TgOvPrP4) that over-
express variable individual levels of the PrP
ARQ ovine prion
protein, were investigated. We showed that PrP
c expression in the
brain of individual TgOvPrP4 mice could be estimated by
measuring PrP
c levels in the sera of the corresponding mice by
ELISA. The transmissibility and uniform features of the TSE
agents involved in atypical scrapie were confirmed by applying this
mouse model to a series of natural isolates and experimental TSE
sources. However, we found that the transmissibility and survival
periods of the mice were much more influenced, than in classical
scrapie or BSE, by (i) the PrP
c expression levels of the mice and (ii)
the prion protein genotypes of the ovine isolates.
Results
We previously reported that, during transmission studies of
classical scrapie and BSE, some inoculated TgOvPrP4 mice failed
to accumulate detectable levels of PrP
res in their brains [20].
Preliminary studies with ELISA showed that the PrP
c levels in the
brains of such mice were much lower [20] than those initially
reported for PrP
c in the first mice bred in this mouse line [5]. We
therefore decided to investigate in greater detail the individual
variations of PrP
c expression in the TgOvPrP4 mouse line and
their possible consequences on the transmission features of TSEs,
notably for atypical scrapie.
Expression levels of the ovine prion protein in TgOvPrP4
mice can be monitored by blood testing
We determined the PrP
c expression levels in TgOvPrP4 mice by
analysing the brains of a series of 47 animals produced after long-
term continuous breeding of the mouse line. Results indicated the
presence of three different subpopulations of TgOvPrP4 mice
(17, 16 and 14 mice respectively), that expressed 5+/21 mg/g,
27+/23 mg/g or 109+/220 mg/g PrP
c respectively, i.e. ,0.25,
1.5 or 66 the PrP
c level measured in a sheep brain control
(19 mg/g) (Figure 1A). In contrast, no significant individual
variability was observed in 7 C57Bl/6 mice, the brains of which
contained 16+/25 mg/g of PrP
c.
Sera from all 47 TgOvPrP4 mice were analysed to see if the
three TgOvPrP4 subpopulations could be distinguished by
analysing a peripheral tissue in the live animal. Before sacrifice,
the serum PrP
c levels in the three TgOvPrP4 mouse subpopula-
tions that respectively expressed ,0.25, 1.5 or 6 times the PrP
c
level expressed in a sheep brain control, were 4+/22 ng/ml,
20+/29 ng/ml and 48+/210 ng/ml PrP
c. In comparison, the
sera PrP
c levels in 15 C57Bl/6 mice were 70+/215 ng/ml.
Repeated measures of the serum PrP
c levels in each TgOvPrP4
mouse prior to sacrifice, every week for 4 weeks (i.e. on day D0,
D7, D14, D21 and D28), resulted in a variation coefficient
(standard deviation/mean) of 16% for the 47 TgOvPrP4 mice and
demonstrated the reliability of the discrimination of the three
TgOvPrP4 subpopulations (Figure 1B). Statistical analyses con-
firmed that the serum PrP
c levels in [TgOvPrP4 (x0.25)] were
significantly lower than those in [TgOvPrP4 (x1.5)] or [TgOvPrP4
(x6)] (t-test, p,0.0001 and p,0.0001 respectively) and that the
serum PrP
c levels in [TgOvPrP4 (x1.5)] were significantly lower
than those in [TgOvPrP4 (x6)] (t-test, p,0.0001). This implied
that PrP
c expression in the brains of TgOvPrP4 mice could be
monitored by measuring the PrP
c levels in the mouse sera. Thus
serum PrP
c levels ,10 ng/ml, 10–40 ng/ml or .40 ng/ml
respectively were found to identify TgOvPrP4 mice expressing
,0.25, 1.5 or 66the PrP
c level measured in a sheep brain control.
Atypical scrapie is transmissible in TgOvPrP4 ovine
transgenic mice
Twelve brain homogenates from atypical scrapie natural isolates
were intracerebrally inoculated into the TgOvPrP4 mouse line
(Table 1). These isolates included 7 sheep and 1 goat with prnp
alleles associated with increased susceptibility to atypical scrapie
(AF141RQ or AHQ) (group 1a) and 4 sheep without such alleles
(group 1b). Most of the inoculated mice (85/90 in group 1a and
37/41 in group 1b) developed clinical symptoms, including
hunched posture, weight loss, reduced mobility, tail chewing,
clasping and difficulty or impossibility to stand up. In 11 of the 12
experiments, the first deaths occurred between 350–450 days post-
inoculation (d.p.i.). Western blot (detecting PrP
res) or IHC
(detecting PrP
sc) analyses indicated the presence of PrP
res/PrP
sc
in 87% and 82% of the mice inoculated with group 1a and group
1b isolates respectively.
For comparison, TgOvPrP4 mice were intracerebrally inocu-
lated with 10 natural scrapie isolates, three classical scrapie with
usual molecular features (i.e. high molecular weight of PrP
res
compared to BSE or CH1641 experimental scrapie source) (group
Figure 1. Levels of transgene expression in transgenic
(TgOvPrP4) mice expressing ovine cellular prion protein (PrP
c).
(A) Quantification of seric and cerebral PrP
c levels by ELISA in 47
TgOvPrP4 mice. (B) Repeated measures of PrP
c in the serum for 4 weeks
(day D0, D7, D14, D21, D28) in 47 TgOvPrP4 mice representing the 3
subpopulations with distinct PrP
c levels in their brain. Each line
represents the average and the standard deviation of 17, 16 and 14
individual mice expressing, respectively, ,0.25, 1.5 or 66the PrP
c level
expressed in a sheep brain control.
doi:10.1371/journal.pone.0007300.g001
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Eighty-six of the 99 inoculated mice developed clinical symptoms
similar to those previously described in mice inoculated with
atypical scrapie isolates. Western blot (detecting PrP
res) or IHC
(detecting PrP
sc) analyses revealed PrP
res/PrP
sc in 93% of the
animals.
Two of the three classical scrapie isolates with usual molecular
features (Class
usual 2 and Class
usual 3) were identified in flocks (b
and a respectively) from which a case of atypical scrapie (Atyp 10
and Atyp 2 respectively, both belonging to group 1a), had been
identified.
These two classical scrapie cases showed long survival periods
(640 and 666 d.p.i. respectively) compared to other classical
scrapie in TgOvPrP4 mice [5,21].
Isolates from the two pairs of atypical and classical scrapie cases
originating from the same flock were also inoculated into C57Bl/6
wild-type mice (Table 2). The 2 classical scrapie isolates (Class
usual
2 and 3) transmitted the disease to these mice (mean survival
periods of 531 and 584 d.p.i) and produced 17% and 35% of
PrP
res/PrP
sc positive mice, respectively. Although the survival
range and mean survival periods (532 and 607 d.p.i. respectively)
were comparable, PrP
res/PrP
sc were not detected in any of the
C57Bl/6 mice inoculated with the 2 atypical scrapie isolates.
Finally TgOvPrP4 mice were also intracerebrally inoculated
with 6 experimental TSE sources, three experimental isolates from
sheep (group 4), and three experimental strains initially derived
from wild-type C57Bl/6 mice (group 5) (Table 3). Sixty-five of the
70 inoculated mice developed clinical symptoms and Western blot
or IHC analyses revealed PrP
res/PrP
sc in 96% of the animals.
Transmission efficacy of atypical scrapie is at least partly
conditioned by the levels of ovine PrP
c in mice
Transmission results in TgOvPrP4 mice were further analysed
in relation to the three patterns of ovine PrP
c expression in mice,
by analysing serum sampled from each mouse at the time of
inoculation (Figure 2).
Table 1. Natural scrapie isolates transmission results to TgOvPrP4 ovine transgenic mice.
Inoculum
(1) Genotype
(2)
Survival periods (dpi)
(mean6SD (range))
No. of PrPres or PrPsc positive
animals/no. Inoculated
Group 1a
Atyp 1 AF141RQ/AF141RQ 386613 (372–408) 11/11
Atyp 2
(a) AF141RQ/AL141RR 401642 (342–477) 8/9
Atyp 3 AF141RQ/AL141RR 4436112 (342–653) 8/10
Atyp 4 AF141RQ/AL141RR 4546119 (341–650) 11/12
Atyp 10
(b) AF141RQ/AL141RR 5966117 (446–757) 8/9
Atyp 8 AF141RQ/AL141RQ 5176137 (379–684) 11/12
Atyp 5 AL141HQ/AL141RR 5206154 (384–740) 9/10
Atyp 12
(Goat) AL141HQ/AL141HQ 6016143 (407–769) 8/12
Group 1b
Atyp 9 AL141RR/AL141RR 5966176 (406–817) 8/10
Atyp 7 AL141RR/AL141RR 5406196 (349–796) 9/9
Atyp 6 AL141RR/AL141RR 4926108 (393–700) 8/9
Atyp 11 AL141RH/AL141RH 623686 (518–743) 8/12
Group 2
Class
usual 1 ARQ/ARQ 314657 (259–477) 10/11
Class
usual 2
(b) ARQ/ARR 640662 (559–775) 12/12
Class
usual 3
(a) ARQ/VRQ 6666101 (496–876) 7/12
Group 3
Class
CH1641-like 1 VRQ/VRQ 248650 (187–357) 10/10
Class
CH1641-like 2 ARQ/ARQ 257657 (202–369) 7/7
Class
CH1641-like 3 ARQ/ARQ 240661 (184–419) 12/12
Class
CH1641-like 4 VRQ/VRQ 364661 (230–408) 12/12
Class
CH1641-like 5 ARQ/ARQ 235653 (142–331) 8/8
Class
CH1641-like 7 ARQ/ARQ 235626 (197–274) 8/8
Class
CH1641-like 8 ARQ/ARQ 240621 (218–262) 7/8
(1)Animals were inoculated intracerebrally with 2 mg brain tissue.
(2)Genotype of sheep or goat (amino acids 136, 141, 154, and 171).
(Goat)Goat isolate.
(a)Isolates detected in the flock a.
(b)Isolates detected in the flock b.
Natural inoculums were divided into 4 different groups, all originating from active surveillance of TSEs in small ruminants. Group 1a: atypical scrapie cases with prnp
alleles associated with increased susceptibility to atypical scrapie (AF141RQ or AHQ). Group 1b: atypical scrapie cases without prnp alleles associated with increased
susceptibility to atypical scrapie. Group 2: classical usual scrapie cases. Group 3: CH1641-like scrapie cases. Detection of PrP
res/PrP
sc was performed by Western blot or
IHC analyses.
doi:10.1371/journal.pone.0007300.t001
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and 3) or experimental TSE sources (groups 4 and 5), negative
PrP
res/PrP
sc brains have been observed, but only in [TgOvPrP4
(x0.25)] mice (9/14) or very rarely in [TgOvPrP4 (x1.5)] mice (1/
97), whereas all the 58 mice from the other group were PrP
res/PrP
sc
positive (Figure 2A). In contrast, some PrP
res/PrP
sc negative mice
were found in all 3 TgOvPrP4 subpopulations inoculated with
atypicalscrapie(group 1aandgroup1b),i.e.not onlyin[TgOvPrP4
(x0.25)] (5/10), but also in a significant proportion of [TgOvPrP4
(x1.5)] (11/49) and even in [TgOvPrP4 (x6)] (2/66) mice.
Differences between the survival periods of PrP
res/PrP
sc positive
mice in the three TgOvPrP4 subpopulations were only observed for
the two atypical scrapie groups. The differences in mean survival
periods between [TgOvPrP4 (x1.5)] and [TgOvPrP4 (x6)] were 43,
11, 66 or 29 days for classical scrapie or BSE (groups 2, 3, 4 and 5
respectively), but were 175 and 260 days for atypical scrapie (groups
1a and 1b respectively). These survival figures for PrP
res/PrP
sc
positive mice (Figure 2B) were subjected to statistical analyses using
the Log-Rank test and the Cox proportional-hazard regression
models. The Log-Rank test revealed that the differences in survival
between [TgOvPrP4 (x1.5)] and [TgOvPrP4 (x6)] mice inoculated
with atypical scrapie were significant (Log-Rank, p,0.0001 and
p=0.015 in groups 1a and 1b respectively) whereas no significant
differences were found between the other groups (Log-Rank,
p=0.76, p=0.429, p=0.224, p=0.231 for groups 2, 3, 4 and 5
respectively). These results were consistent with the Cox propor-
tional-hazard regression model results which showed a significant
effect of serum PrP
c levels on the survival period for mice inoculated
with atypical scrapie (Wald test p=,0.0001 for both groups 1a and
1b), but did not suggest any effect of PrP
c expression levels in the
PrP
res/PrP
sc positive mice inoculated with classical scrapie or BSE
(Wald test, p=0.51, p=0.09, p=0.053 and p=0.14 in groups 2, 3,
4 and 5 respectively).
The hazard ratios associated with the serum PrP
c levels for
atypical scrapie are indicated in Table 4. The PrP
c expression levels
significantly increased the risk of death whatever the genotype
group (groups 1a, 1b); an increase of one unit (ng/ml) in the serum
PrP
c level corresponded to an increased risk of death of 3%. When
the serum PrP
c level of 4 ng/ml ([TgOvPrP4 (x0.25)] mean value)
was set as the baseline category, the hazard ratios and their 95%
confidenceintervalswere1.53 (95%CI:1.34–1.76)foraserumPrP
c
level of 20 ng/ml ([TgOvPrP4 (x1.5)] mean value) and 3.24 (95%
CI: 2.22–4.71) for a serum PrP
c level of 48 ng/ml ([TgOvPrP4 (x6)]
mean value); this corresponded to an increased risk of 53% and
224% for the [TgOvPrP4 (x1.5)] and [TgOvPrP4 (x6)] groups
respectively compared to the [TgOvPrP4 (x0.25)] group.
Transmission of atypical scrapie is conditioned by the
prnp genotype of sheep at codons 141 and 154
The transmission results for atypical scrapie were also analysed
in relation to the prnp genotype of the sheep that were the source of
the infectious agent, by comparing group 1a (animals with
Table 2. Natural scrapie isolates transmission results to C57Bl/6 wild-type mice.
Inoculum
(1) Genotype
(2)
Survival periods (dpi)
(mean6SD (range))
No. of PrPres or PrPsc positive
animals/no. Inoculated
Atyp 2
(a) AF141RQ/AL141RR 5326118 (285–685) 0/17
Atyp 10
(b) AF141RQ/AL141RR 6076107 (369–860) 0/18
Class
usual 2
(b) ARQ/ARR 531694 (317–645) 3/18
Class
usual 3
(a) ARQ/VRQ 584652 (481–642) 6/17
(1)Animals were inoculated intracerebrally with 2 mg brain tissue.
(2)Genotype of sheep or goat (amino acids 136, 141, 154, and 171).
(a)Isolates detected in the flock a.
(b)Isolates detected in the flock b.
Detection of PrP
res/PrP
sc was performed by Western blot or IHC analyses.
doi:10.1371/journal.pone.0007300.t002
Table 3. Experimental TSEs transmission results to TgOvPrP4 ovine transgenic mice.
Inoculum
(1) Genotype
(2)
Survival periods (dpi)
(mean6SD (range))
No. of PrPres or PrPsc positive
animals/no. Inoculated
Group 4
SSBP1 VRQ/VRQ 4376107 (330–656) 11/12
CH1641 AXQ/AXQ 231649 (186–355) 12/12
BSE
OVINE ARQ/VRQ 436636 (357–461) 10/10
Group 5
BSE – 375651 (341–531) 12/12
C506M3 – 332625 (295–377) 12/12
87V – 290668 (211–390) 10/12
(1)Animals were inoculated intracerebrally with 2 mg brain tissue.
(2)Genotype of sheep or goat (amino acids 136, 141, 154, and 171).
Experimental inoculums were divided into 2 different groups. Group 3: small ruminants intracerebrally inoculated with various TSEs. Group 4: experimental strains
initially derived from wild-type mice. Detection of PrP
res/PrP
sc was performed by Western blot or IHC analyses.
doi:10.1371/journal.pone.0007300.t003
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or AHQ prnp alleles) and group 1b (animals without AF141RQ or
AHQ prnp alleles) [14,15].
The Kaplan-Meier survival curves for PrP
res/PrP
sc positive
mice (Figure 2B) showed that 98% of the [TgOvPrP4 (x6)] mice in
group 1a died at around 400 d.p.i and 25% of the [TgOvPrP4
(x1.5)] mice died before 600 d.p.i. In contrast, in group 1b, 20% of
the [TgOvPrP4 (x6)] mice died after 600 d.p.i and all the
[TgOvPrP4 (x1.5)] mice died after 666 d.p.i.. The significant
difference in survival between groups 1a and 1b, according to the
Cox proportional-hazard regression model was confirmed by
statistical analyses (Wald test p,0.0001). For the hazard ratios, the
risk was 4.32 fold (95 CI: 2.5–7.19) higher in group 1a than in
group 1b whatever the PrP
c expression level (Table 5). The risk
was thus significantly higher in group 1a than in group 1b.
A consistent biochemical signature of atypical scrapie in
TgOvPrP4 mice
Finally, detailed biochemical studies were performed to
characterize the PrP
res from mouse brains. When the Sha 31
monoclonal antibody was used for PrP
res detection, the usual 3-
band pattern (between 18–20 and 30 kDa), that became a single
Figure 2. Effects of variable PrP
c expression levels in TgOvPrP4 mice on TSEs transmission. Survival periods of PrP
sc positive TgOvPrP4
mice are shown according the level of PrP
c expression (,0.25, 1.5 or 66the PrP
c level expressed in a sheep brain control) and to the inoculums;
Group 1a: atypical scrapie isolates carrying the AF141RQ or AHQ alleles, Group 1b: atypical scrapie isolates without the AF141RQ or AHQ alleles, Group
2: usual classical scrapie isolates, Group 3: CH1641-like scrapie isolates, Group 4: experimental isolates (SSBP1, CH1641, BSE
OVINE), Group 5: mouse-
adapted strains (BSE, C506M3, 87V). (A) Transmission results. (B) Kaplan-Meier survival curves of PrP
res/PrP
sc positive mice expressing ,1.5 (blue line)
or ,66 (red line) the PrP
c level expressed in a sheep brain control for each of the 6 different groups. p-values represent log-rank differences in
cumulative survival between mice expressing ,1.5 and ,66the PrP
c level expressed in a sheep brain control.
doi:10.1371/journal.pone.0007300.g002
Table 4. Statistical analysis of PrP
c levels influencing survival
period of TgOvPrP4 mice inoculated with atypical scrapie.
PrP
c level Hazard ratio 95% CI
48 ng/ml: [TgOvPrP4 (x6)] 1
* –
20 ng/ml: [TgOvPrP4 (x1.5)] 1.53 (1.34–1.76)
48 ng/ml: [TgOvPrP4 (x6)] 3.24 (2.22–4.71)
*PrP
c level set as the baseline category.
Hazard ratios calculated from model used to identify predictors of survival for
mice inoculated with atypical scrapie isolates and illustrating the effect
associated with PrP
c sera levels (the mean of each subpopulation were chosen
to illustrate the effect of the PrP
c sera level).
doi:10.1371/journal.pone.0007300.t004
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observed in all TgOvPrP4 and C57Bl/6 PrP
res positive mice
inoculated with classical scrapie or BSE (groups 2, 3, 4 and 5) (data
not shown). In contrast, a complex pattern with five major bands
between 31 and 10 kDa (named bands I to V), was observed in all
53 PrP
res positive TgOvPrP4 mice inoculated with the 12 atypical
scrapie cases (Figure 3A). Three PrP
res fragments with apparent
molecular masses of ,24, 18 and 11 kDa (PrP
res A, B and C
respectively) were detected after PNGase deglycosylation
(Figure 3B).
The biochemical features of PrP
res in mice inoculated with
atypical scrapie, before and after PNGase deglycosylation, were
compared by using different monoclonal antibodies that recog-
nised different prion protein sequences along the protein,
including 4F2 (62–93), P4 (93–99), Sha 31 (148–155) and 99/
97.6.1 (221–224). After PNGase deglycosylation, we noted non-
specific immunostaining at ,29 kDa with all monoclonal
antibodies (4F2, P4 and 99/97.6.1) revealed with peroxidase-
labeled conjugates against mouse immunoglobulins, also present in
uninfected mice. All three different PrP
res protease cleavage
products were detected by antibodies P4 and Sha 31, whereas 4F2
did not detect PrP
res C (Figure 3B). The 99/97.6.1 antibody
showed lower sensitivity but reacted more strongly with PrP
res A
than with PrP
res B. Prior to deglycosylation, 99/97.6.1 did not
immunostain bands III, IV and V (21, 17 and 11 kDa) (Figure 3A).
All together our data suggest that the C-terminal epitope
recognised by this latter antibody might be present in PrP
res A
but only faintly in PrP
res B fragments (Figure 4).
PrP
res Western blot profiles from 30 mice representative of the
different sheep genotypes and of the three subpopulations of
TgOvPrP4 mice were subjected to repeated analyses and
quantification. The variability of the apparent band molecular
weights between mice was only slight with a coefficient variation
(standard deviation/mean) of 2% for bands I to IV and 7% for
band V (Figure 3A), and similar to that observed for repeated
measures from the same brain sample (2.1+/21.2% for bands
above 16 kDa and 4.0+/21.7% for the band around 11 kDa).
Table 5. Statistical analysis of prnp genotype influencing
survival period of TgOvPrP4 mice inoculated with atypical
scrapie.
Category Hazard ratio 95% CI
Group 1b 1
** –
Group 1a 4.32 (2.50–7.19)
**Group set as the baseline category.
doi:10.1371/journal.pone.0007300.t005
Figure 3. Western blot profiles of PrP
res in TgOvPrP4 mice infected with atypical scrapie. Results are shown before (A) and after (B)
PNGase deglycosylation using monoclonal antibodies 4F2 (lanes 1, 5), P4 (lanes 2, 6) (N-terminal), Sha 31 (lanes 4, 8)(core) and 99/97.6.1 (lanes 3, 7)(C-
terminal). Western blot profiles with Sha 31 antibody are shown with the curve of chemiluminescence measured along the lanes. Apparent molecular
weights were means from 30 mice before PNGase deglycosylation and from 7 mice after PNGase deglycosylation.
doi:10.1371/journal.pone.0007300.g003
Atypical Scrapie Transmission
PLoS ONE | www.plosone.org 6 October 2009 | Volume 4 | Issue 10 | e7300The variability was similar following PNGase deglycosylation of
PrP
res in 7 mice from three different experiments (Atyp 1, 2, 6),
with a coefficient variation of 2% for PrP
res A and B and 4% for
PrP
res C (Figure 3B). These data do not indicate any change in
PrP
res patterns associated with either the PrP
c levels of the mice or
the prnp genotypes of the sheep or goats.
Discussion
Characterization of the infectious agents involved in TSEs has
historically required transmission in inbred wild-type mice, such as
C57Bl, VM or RIII [4,22,23]. However some TSEs, such as the
CH1641 experimental scrapie source [24] or some human TSEs
[25] fail to transmit to wild-type mice of any genotype. The recent
availability of transgenic mice expressing the prion gene of the
natural host of the disease has facilitated TSE transmission studies,
as in the use of ovine transgenic mice for scrapie or BSE [5,20,21].
The strain-specific molecular diversity of the classical scrapie or
BSE sources was faithfully reproduced in the TgOvPrP4 ovine
transgenic mouse model that we have developed. However, a
novel TSE, called atypical scrapie or Nor98, has recently been
identified in sheep and goats throughout Europe [12]. In several
countries this disease is now more frequent than classical scrapie
and in some countries atypical scrapie has been recognized in the
absence of classical scrapie [26–28]. The experimental transmis-
sibility of this disease was established in a transgenic mouse model
(tg338) that strongly over-expresses (8- to 10-fold) the VRQ allele
of ovine prion protein, from a series of 10 French atypical scrapie
Figure 4. Schematic representation of PrP
res fragments identified in atypical scrapie. (A) Diagram illustrating PrP
res A, B and C sequences
in atypical scrapie, with location of epitopes recognised by monoclonal antibodies used during the study and estimated cleavages of PrP
res
fragments. (B) Diagram of Western blot profiles of PrP
res detected using Sha 31 monoclonal antibody before (1) and after (2) PNGase deglycosylation.
doi:10.1371/journal.pone.0007300.g004
Atypical Scrapie Transmission
PLoS ONE | www.plosone.org 7 October 2009 | Volume 4 | Issue 10 | e7300cases and 2 Norwegian Nor98 isolates [17]. In contrast,
experimental transmission was not achieved in wild-type mice
[12,17] or in bank voles [29]. Overall this clearly confirmed that
atypical scrapie is a genuine TSE associated with infectious prions.
In this study we confirmed the transmissibility of atypical
scrapie, after intracerebral challenge, in another ovine transgenic
mouse model (TgOvPrP4), but failed to transmit the disease from
2 cases into wild-type mice. Twelve cases, including the 10 French
isolates previously transmitted to the tg338 mouse line [17], were
successfully transmitted to TgOvPrP4 mice that over-expressed
the AL141RQ prion protein. Although this prnp genotype of
TgOvPrP4 mice is only rarely identified in sheep with atypical
scrapie [13–16,26,30–33], most of the inoculated mice accumu-
lated the pathological prion protein in their brain. Biochemical
analysis of PrP
res showed a fully conserved pattern comparable to
that previously described in the natural host [15], i.e. a similar
complex pattern including 5 major bands derived from 3 distinct
PrP
res products. Both PrP
res fragments cleaved at both N- and C-
terminal ends, and the uncleaved (or marginally cleaved) PrP
res,
were consistently maintained after transmission into ovine
transgenic mice (Figure 4). The consistency of the Western blot
profiles, whatever the isolate, and in line with previous studies in
tg338 ovine transgenic mice, does not suggest any diversity in
atypical scrapie. This consistent PrP
res glycoprofile is somewhat
reminiscent of certain PrP
res features in patients with Gerstmann-
Strau ¨ssler-Scheinker syndrome [34–36].
This study enabled us to extend the descriptive profile of our
TgOvPrP4 mouse model and examine TSE transmission factors in
relation to the level of expression of the prion protein by the
infected host. After long-term breeding of the mouse line we
indeed found three TgOvPrP4 mice subpopulations expressing in
their brain ,0.25, 1.5 or 66the PrP
c level measured in a sheep
brain control. We then decided to evaluate the possible influence
of these differences in PrP
c levels in the central nervous system on
TSE development, following the inoculation of 3 mouse-adapted
strains (BSE, C506M3, 87V), 3 experimental small ruminants
isolates (SSBP1, CH1641, BSE
OVINE) and 22 small ruminant
natural isolates collected by active surveillance of TSEs in sheep
and goats (10 classical scrapie isolates, including 3 usual isolates as
shown by PrP
res molecular analysis and 7 ‘‘CH1641-like’’ isolates;
12 atypical scrapie isolates). This panel of samples thus represents
the molecular diversity of TSEs in small ruminants, especially with
the three basic PrP
res phenotypes possibly demonstrated by
Western blot in natural scrapie. Strikingly the influence of the
PrP
c expression level was much more obvious for the atypical
scrapie isolates, and a considerable delay in disease onset was
associated with a decrease in PrP
c expression levels,. TgOvPrP4
mice with higher PrP
c levels (,66) died after shorter periods
(around 400 days) than mice with lower PrP
c levels (,1.56)
(around 700 days). Comparisons of different transgenic mouse
lines already indicated that the expression levels of the prion
protein were inversely related to the incubation period in classical
scrapie [6]. Nevertheless, to the best of our knowledge, the variable
influence of PrP
c expression levels according to the form of prion
disease defined by its essential molecular features, has never been
described and is here reported between different animals in a same
transgenic mouse line. However, although the development of
atypical scrapie appears to be much more facilitated by increased
PrP
c expression, this also suggests that the risk of transmission in
animals expressing physiological levels of the protein would be
relatively low. This characteristic, in addition to the species
barrier, would help to explain the failure to transmit atypical
scrapie to wild-type mice (RIII, VM and C56Bl mice) [17] or bank
voles [29], unlike classical scrapie. Besides, a major influence of the
PrP
c expression levels has been demonstrated in transgenic mice
over-expressing (i) mutated human prion protein linked to
Gerstmann–Stra ¨ussler-Scheinker syndrome [37,38] or (ii) a prion
protein with a nine-octapeptide insertion associated with a human
familial prion disease [39,40]. In both cases disease development
was strongly conditioned by the levels of transgene expressions, not
only following inoculations of brain tissues from affected patients,
but also spontaneously.
Our demonstration that atypical scrapie was much more
influenced by PrP
c expression levels than classical scrapie or
BSE was possible in this mouse model solely because our approach
was based on serum PrP
c measurements. These were indeed found
to reflect the levels of PrP
c expression in the brain. In this model
protein expression was controlled by the neuron-specific enolase
promoter and neither RT-PCR or Western blot analyses were able
to detect expression of the prnp gene in non nervous tissues [5,41].
One explanation of the close relationship between serum and
cerebral PrP
c might be related to a release of PrP
c from the central
nervous system into the blood, as was also shown for some other
neuronal proteins [42]. It is noteworthy that the plasma
concentration of PrP
c in wild-type C57Bl mice (,70+/215 ng/
ml) is much higher than in TgOvPrP4 mice, even in [TgOvPrP4
(x6)] with the highest level of expression (48+/210 ng/ml). This
suggests that a fraction of the PrP
c in the serum of wild-type mice
could originate from the nervous system, under physiological
conditions. Importantly, direct evidence that PrP
c readily crosses
the blood brain barrier in both brain-to-blood and blood-to-brain
directions has recently been reported [43]. Regarding the
TgOvPrP4 mouse line, the presence of [TgOvPrP4 (x0.25)]
animals which express low levels of PrP
c clearly represents a
drawback for transmission studies of TSEs. This can however be
circumvented by assessing the PrP
c expression levels in each
individual mouse prior to its use in animal experiments.
Furthermore, although this subpopulation increased following
long-term random breeding of the mouse line, blood testing is also
used to monitor PrP
c expression levels during breeding in order to
eliminate those breeders that produce progeny with a high
proportion of poorly expressing animals. It should be noted that
no indication of variation of transgene expression was found in a
similarly produced mouse line (TgOvPrP59) originating from
different founders [44,45], which makes it unlikely that our
observations in the TgOvPrP4 mouse line result from factors
intrinsic to the transgene construct and/or the genetic background
of the mice. However, the loss of transgene expression in a
transgenic line is not unprecedented and two types of explanation
are generally provided to account for such a loss. These include (1)
integration of the transgene in an heterochromatin-rich region
which results in silencing of the transgene in some cells (position
effect variegation) [46] or (2) the repetitive nature of the transgene
arrays which induces the formation of heterochromatin at the sites
of integration and leads to gene silencing [47]. In addition, our
genetic construction does not contain any insulators, which
suggests that heterochromatin propagation might be a cause of
transgene extinction in some animals [48].
Concerning the factors involved in the transmission of atypical
scrapie, we were also surprised to demonstrate the influence of the
prnp genotypes of the sheep or goat donors on development of the
disease in TgOvPrP4 inoculated mice. This had not been observed
in tg338 mice, which overall showed more rapid incubation of the
disease [17]. Lower PrP
c expression levels in TgOvPrP4 mice were
required to transmit atypical scrapie, when the isolates carried the
AF141RQ or AHQ alleles associated with increased susceptibility
to the disease in sheep [14]. The same analysis of possible
differences associated with the susceptible or resistant genotype, as
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scrapie or BSE considering the available isolates. Among these
sources only one classical scrapie isolates (Class
usual 2) carried the
ARR allele known to be associated with resistance to clinical
scrapie [49,50]. Although the ARR allele is rarely observed in
classical scrapie we here confirmed, by both PrP
res analyses in
sheep and bioassays in wild-type and ovine transgenic mice, that it
is possible to detect classical scrapie in relatively resistant animals
during the implementation of flock analysis of scrapie cases [51].
Overall, given the limited number of samples available we cannot
exclude a possible influence of the prnp genotypes for classical
scrapie or BSE. The results observed with atypical scrapie are
difficult to explain and we cannot exclude differences in infectious
titres between the two groups of samples examined, in relation to
(i) possible differences in the distribution of infectivity within the
CNS [52] and/or (ii) different stages in the incubation periods in
sheep and goats. On the other hand the AF141RQ or AHQ prnp
alleles were associated with a lower conformational stability of the
ovine PrP
c protein [53], which might be associated with an
increased capacity of the PrP
sc of such genotypes to transconform
PrP
c. It is noteworthy that only one successful experimental
transmission of atypical scrapie has so far been reported in sheep,
which was obtained in an AHQ homozygous sheep intracerebrally
inoculated with an atypical scrapie isolate from an AHQ
homozygous sheep [18]. However the apparently spontaneous
occurrence of three cases of atypical scrapie in genetically
susceptible sheep was also reported in a flock derived from sheep
imported from New Zealand, a country regarded as scrapie-free
[54].
Based on our findings, the possibility that variations in the
expression of ovine PrP
c might be factors involved in susceptibility
to atypical scrapie in sheep and goats, is open to question. A
second proposal could question whether a failure of the protein
quality-control systems might also be involved in susceptibility to
atypical scrapie. Recent studies have provided new evidence for a
role of these systems in the conversion of PrP
c to an abnormal
form of prion protein, with either impairment of proteasomal
degradation or endoplasmic reticulum stress, leading to the
generation of a misfolded form of prion protein [55–57].
Transgenic mice were also reported to develop a spontaneous
neurological disease in the absence of PrP
sc when preferentially
expressing a transmembrane form of prion protein (PrP
Ctm)
[58,59], which would imply that
CtmPrP is a key component in the
pathway of neurodegeneration as in Gerstmann–Stra ¨ussler-
Scheinker syndrome.
However our data do emphasize the unresolved questions
regarding the origin of atypical scrapie, which as yet remains
unknown. A spontaneous origin of the disease is suspected, and
importantly, no evidence of natural transmissibility in small
ruminants has been observed [33,60]. The results of our novel
approach, based on monitoring prion protein expression in
animals from the same transgenic mouse line, suggest that the
risk of transmission of atypical scrapie is intrinsically lower than
that of classical scrapie or BSE, especially in relation to the
expression level of the prion protein.
Materials and Methods
Biological samples
The samples differed by their origin and nature (natural scrapie
isolates and experimental samples). Groups 1a, 1b, 2 and 3 are
natural samples collected by active surveillance of scrapie,
suggesting that these most probably have been sampled before
any clinical disease. In contrast, groups 4–5 included experimental
samples derived from animals intracerebrally inoculated with TSE
then sacrificed at the stage of clinical disease.
Natural scrapie isolates (Table 1) were obtained from 21 sheep
and 1 goat previously classified as atypical (group 1a and 1b:
categorized according to the presence/absence of prnp alleles
associated with increased susceptibility to this disease (AF141RQ or
AHQ)) (n=12, Atyp), classical usual (group 2) (n=3, Class
usual)o r
‘‘CH1641-like’’ (n=7, Class
CH1641-like) scrapie cases according to
the PrP
res molecular phenotype of the isolates. Group 2 contains
classical scrapie isolates with ‘‘usual’’ PrP
res molecular features, i.e.
a higher apparent molecular mass compared to ovine BSE or to
the CH1641 experimental scrapie isolate [61], whereas group 3
contains unusual ‘‘CH1641-like’’ isolates that show similar PrPres
molecular features to that of CH1641 [62–64]. Natural scrapie
isolates included two pairs of atypical/classical usual scrapie cases
originating from the same flocks (Atyp 2/Class
usual 3 in flock a and
Atyp 10/Class
usual 2 in flock b). The genotypes and PrP
res
biochemical features of atypical cases have been described
previously [15].
Experimental isolates (group 4) (SSBP/1, CH1641, BSE
OVINE)
were obtained from small ruminants intracerebrally inoculated
with SSBP/1 (Sheep Scrapie Brain Pool 1) and CH1641 scrapie
isolates (kindly provided by N. Hunter, Institute for Animal
Health, Edinburgh, United Kingdom) or with a French bovine
BSE case [61]. Transmission studies of these isolates in TgOvPrP4
and C57Bl/6 mice have been reported previously [20].
Experimental strains (group 5) (BSE, C506M3, 87V), derived
from mouse-adapted strains [20], were used at a second passage
from TgOvPrP4 mice.
Ovine PrP
c levels in mouse sera and brain
The TgOvPrP4 ovine transgenic mice have already been
described [5]. These mice express the ovine prion protein (A136
R154 Q171) open reading frame that had been inserted into the
pNSE-Ex4 vector (neuron specific enolase promoter). Transgenic
founders were crossed with prion protein knockout mice to obtain
homozygous mice for both the ovine prnp transgene and the
deletion of the murine prnp locus.
The levels of PrP
c in TgOvPrP4 and C57Bl/6 (Charles River,
L’Arbresle, France) mouse serum or brain were measured using an
ELISA (Enzyme Linked Immuno Sorbent Assay) method as
previously described [65,66], involving two different two-site
immunometric assay based on two different combinations of
monoclonal antibodies. The capture antibodies were 11C6
(recognised epitope unidentified) [67] and SAF34 (octa-repeat
region) [68] for mouse sera and brains respectively. In each case,
the tracer antibody was Bar 224 (141–152 prion protein sequence
in human) as Fab’ acetylcholinesterase conjugate. Sera samples
were centrifuged (5000 rpm, 5 min) prior to dilution of the sera
(1/5 for TgOvPrP4, 1/10 for C57Bl/6) in EIA buffer (100 mM
potassium phosphate buffer pH 7.4, 0.15M NaCI, 0.1% sodium
azide). Brain samples were prepared as 20% homogenates in 5%
(w/v) glucose prior to dilution (1/100) in EIA buffer. Samples
(100 ml per well in duplicate) were loaded in ELISA microtiter
plates (Immunoplate, Maxisorp, Nunc) coated with capture
antibodies. After two hours at room temperature, the plates were
washed with EIA buffer before addition of the conjugate antibody
(2 Ellman’s units per ml EIA buffer). After 2 hours at room
temperature, the plates were washed again in potassium phosphate
buffer 10 mM, and Tween 20 (0.05%, pH 7.4). The colorimetric
substrate (Ellman’s reagent) was then added (200 ml per well).
Absorbance was measured at 410 nm after 30 min of enzyme
reaction. The concentration of PrP
c was estimated by reference to
a standard curve established with a series dilutions of sheep
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reproducible linear curve with a detection limit close to 2 ng/ml
for serum and 2 mg/g for brain.
Mouse transmission assays
Prior to inoculation, a sample of serum was taken from each
TgOvPrP4 mouse. Experimental groups of four to six week old
female TgOvPrP4 or C57Bl/6 (Charles River, L’Arbresle, France)
mice were anaesthetized (80 ml of 0.8% ketamin –0.12% xylazine)
then inoculated intracerebrally (20 ml per mouse) with a 10%
solution (wt/vol) of homogenates prepared from CNS samples of
TSE cases in glucose (5%). The mice were cared for and housed in
the Biohazard prevention area (A3) of our institution, according to
the European guidelines (directive 86/609/EEC) and the French
Ethical Committee (decree 87–848), and were supplied with food
and drink ad libitum. They were checked at least twice weekly for
the presence of clinical signs. When signs occurred, the mice were
monitored daily and were sacrificed with an anaesthetic solution
overdose (200 ml of 0.8% ketamin –0.12% xylazin) if they
exhibited any signs of distress or confirmed evolution of clinical
signs of prion disease. A few animals were found dead. The whole
brain of every second mouse was frozen and stored at 280uC
before Western blot analysis for PrP
res detection ; the other brains
were fixed in 10% buffered formalin solution for PrP
sc histopath-
ological analysis. All procedures were agreed (Nu98) by the
CREEA (Regional Committee for Ethical Experimentation on
Animals).
Statistical analysis
Plots of survival curves obtained by Kaplan-Meier method were
displayed for TgOvPrP4 mice overexpressing 1.5 or 66 the
PrP
ARQ ovine prion protein in each of the six inoculum groups.
Log-Rank tests were computed for each group to assess any
survival difference between the two levels. Cox proportional-
hazard regression models were used to identify predictors of the
survival of PrP
res/PrP
sc positive inoculated mice. For the mice
inoculated with atypical scrapie isolates (groups 1a and 1b), a
model was used to assess the effect of the PrP
c expression levels (a
continuous variable) and the prion protein genotype of the animal
that was the source of the infectious agent, at 2 factor levels: high
susceptibility to atypical scrapie (group 1a: animals with AF141RQ
or AHQ prnp alleles) and low susceptibility to atypical scrapie
(group 1b: animals without AF141RQ or AHQ prnp alleles) [14,15].
The interaction between the PrP
c expression level and the PrP
c
genotype was tested with the likelihood ratio test.
A Cox model was also applied to the mice inoculated with
classical usual scrapie isolates, ‘‘CH1641-like’’ scrapie isolates,
experimental TSEs isolates and mouse-adapted strains, to assess
the sole effect of PrP
c expression level. Survival period was
computed as the period between inoculation and death.
Proportional hazard assumptions were checked for all models by
correlating the corresponding set of scaled Schoenfeld residuals
with a suitable transformation of time as proposed by P. Grambsch
& al. [70]. The statistical analysis was performed with R software
(R version 2-6.0 (2007-11-03): A language and environment for
statistical computing. R Foundation for Statistical Computing,
Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-
project.org).
Western blot analysis of PrP
res
Brain samples were examined by TeSeE WB (Bio-Rad)
following the manufacturer’s recommendations, as previously
described [15]. Briefly after PrP
res extractions from 20% brain
homogenates and denaturation in Laemmli solution completed
with 5% (v/v) b-mercaptoethanol and 2% (w/v) sodium dodecyl
sulfate (SDS), the electrophoretic separation was obtained using
15% (resolving gel) and 4% (stacking gel) home-made acrylamide
SDS-PAGE gels (200 V, 60 min). After transferring the proteins
onto a PVDF membrane (115 V, 60 min), the membranes were
incubated 30 min at room temperature with monoclonal antibod-
ies including Sha 31 (4 mg/ml in PBST) [71], P4 (1/2500 in PBST)
(R-Biopharm), 4F2 (1/2500 in PBST) and 99/97.6.1 (1/2500 in
PBST) (kindly provided by K. O’Rourke, USDA, Pullmann, USA)
that recognized the ovine sequences YEDRYYRE (148–155),
WGQGGSH (93–99), QPHGGGW (62–93) and YQRE (221–
224) (J. Langeveld, unpublished Pepscan data) respectively. The
membranes were then incubated with peroxidase-labeled conju-
gates against mouse immunoglobulins (1/2500 in PBST) (Ozyme),
except for the Sha 31 antibody which was revealed with TeSeE
WB (Bio-Rad) according to the manufacturer’s recommendations.
The ECL Western Blotting detection system by enhanced
chemiluminescent reaction (ECL, Amersham or Supersignal,
Pierce) was then applied. Images were analysed using the Versa
Doc analysis system (Bio-Rad) and Quantity OneH software (Bio-
Rad) [15]. Some experiments involved deglycosylation experi-
ments with PNGase F following the Ozyme manufacturer’s
instructions (P0704S). After PrP
res purification, the supernatants
were treated with PNGase F for 1 h at 37uC (reaction buffer 1X,
10% NP-40, PNGase F), then heated at 100uC for 5 min before
Western blot analysis.
PrP
sc immunohistochemistery
Fixed brains were routinely embedded in paraffin after a 1 hour
formic acid (98%–100%) treatment at room temperature. De-
waxed and re-hydrated 5 mm brain sections were immunostained
for PrP
sc using SAF84 (SPI Bio) and 2G11 (Pourquier) monoclonal
antibodies with or without an additional step using streptomycin
sulfate, following a procedure reported in detail elsewhere [72]. A
peroxidase-labeled avidin-biotin complex (Vectastain Elite ABC,
Vector Laboratories) was used to amplify the signal. Final
detection was achieved using a solution of diaminobenzidine
intensified with nickel chloride (Zymed), producing black deposits.
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